BB BIOTECH NAM. SF 0,20/ CH0038389992 /
| 3/24/2023 5:35:54 PM | Chg. -0.20 | Volume | Bid3/24/2023 | Ask3/24/2023 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 52.60EUR | -0.38% | 15,842 Turnover: 828,870.90 |
-Bid Size: - | -Ask Size: - | 2.91 bill.EUR | - | - |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -7.31 CHF | -158.57% |
| EPS Diluted: | -7.31 CHF | - |
| Revenues per Share: | 0.00 CHF | -100.00% |
| Book Value per Share: | 59.27 CHF | -15.54% |
| Cash Flow per Share: | -1.71 CHF | - |
| Dividend per Share: | 3.85 CHF | 6.94% |
| Total | in mill. | |
| Revenues: | 0.01 CHF | -100.00% |
| Net Income: | -404.80 CHF | -158.56% |
| Operating Cash Flow: | -94.80 CHF | - |
| Cash and Cash Equivalents: | 2.80 CHF | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 287,732.31 | 427,411.00 |
| P/BV ratio: | 0.88 | 1.30 |
| P/CF Ratio: | -30.35 | -45.09 |
| PEG: | 0.04 | - |
| Earnings Yield: | -14.07% | -9.48% |
| Dividend Yield: | 7.41% | 4.99% |
| Market Capitalization | ||
| Market Capitalization: | 2.91 bill. EUR | 4.12 bill. EUR |
| Free Float Market Cap.: | 2.8 bill. EUR | 3.97 bill. EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 55.4 mill. | |
Profitability
| Gross Profit Margin: | 100.00% |
| EBIT Margin: | -4,047,000.00% |
| Net Profit Margin: | -4,048,000.00% |
| Return on Equity: | -12.33% |
| Return on Assets: | -11.11% |
Financial Strength
| Liquidity I / Cash Ratio: | 1,010.51% |
| Liquidity II / Quick Ratio: | 1,010.51% |
| Liquidity III / Current Ratio: | 1,010.57% |
| Debt / Equity Ratio: | 10.98% |
| Dynam. Debt / Equity Ratio: | -380.38% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - CHF |
| Revenues / Employee: | - CHF |
| Net Income / Employee: | - CHF |
| Total Assets / Employee: | - CHF |
| * Fiscal Year End: | 12/31/2021 |
| Accounting Standard: | US GAAP |
| Currency: | CHF |